While seed and late-stage funding declined massively in 2022 compared to 2021, early-stage funding in the healthtech sector saw a 26% rise year-on-year.
The drop is majorly due to a massive decline in late-stage investments from $2.4 billion in 2021 to $606 million in 2022, a drop of 75 per cent, according to data from Tracxn, a global SaaS-based market intelligence platform.Seed
Total funding into healthtech companies in India plunged 55 per cent (year-on-year) to $1.4 billion last year, a report showed on Wednesday.The drop is majorly due to a massive decline in late-stage investments from $2.4 billion in 2021 to $606 .
The drop is majorly due to a massive decline in late-stage investments from $2.4 billion in 2021 to $606 million in 2022, a drop of 75 per cent, according to data from Tracxn, a global SaaS-based market intelligence platform.Seed
New Delhi, March 29 (IANS) Total funding into healthtech companies in India plunged 55 per cent (year-on-year) to $1.4 billion last year, a report showed on